# Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)

> **NCT04281290** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Centre Ljubljana** · enrollment: 10 (actual)

## Conditions studied

- Pancreas Cancer

## Interventions

- **PROCEDURE:** Electrochemotherapy - electroporation with Cliniporator Vitae® and chemotherapy drug Bleomycin PHC 15 e. (United States Pharmacopeia - USP)

## Key facts

- **NCT ID:** NCT04281290
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-13
- **Primary completion:** 2023-05-08
- **Final completion:** 2026-05-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04281290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04281290, "Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04281290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*